Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01847274
Title A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
GSK Investigational Site Phoenix Arizona 85013 United States Details
GSK Investigational Site Tucson Arizona 85704 United States Details
GSK Investigational Site Los Angeles California 90027 United States Details
GSK Investigational Site Los Angeles California 90048 United States Details
GSK Investigational Site Palo Alto California 94304 United States Details
GSK Investigational Site San Francisco California 94109 United States Details
GSK Investigational Site New Haven Connecticut 06510 United States Details
GSK Investigational Site Sarasota Florida 34232 United States Details
GSK Investigational Site Tampa Florida 33612 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Chicago Illinois 60611 United States Details
GSK Investigational Site Indianapolis Indiana 46202 United States Details
GSK Investigational Site Indianapolis Indiana 46260 United States Details
GSK Investigational Site Boston Massachusetts 02115 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Burlington Massachusetts 01805 United States Details
GSK Investigational Site Minneapolis Minnesota 55404 United States Details
GSK Investigational Site Minneapolis Minnesota 55455 United States Details
GSK Investigational Site Rochester Minnesota 55905 United States Details
GSK Investigational Site Morristown New Jersey 07962-1956 United States Details
GSK Investigational Site Farmington New Mexico 87401 United States Details
GSK Investigational Site Lake Success New York 11042 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Durham North Carolina 27710 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Vancouver Oregon 98684 United States Details
GSK Investigational Site Abington Pennsylvania 19001-3788 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Austin Texas 78731 United States Details
GSK Investigational Site Dallas Texas 75390 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site The Woodlands Texas 77380 United States Details
GSK Investigational Site Graz A-8036 Austria Details
GSK Investigational Site Innsbruck A-6020 Austria Details
GSK Investigational Site Wien 1090 Austria Details
GSK Investigational Site Edegem 2650 Belgium Details
GSK Investigational Site Kortrijk 8500 Belgium Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Liège 4000 Belgium Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Kelowna British Columbia V1Y 5L3 Canada Details
GSK Investigational Site Vancouver British Columbia V5Z 4E6 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H2L 4M1 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Sherbrooke Quebec J1H 5N4 Canada Details
GSK Investigational Site Aalborg 9100 Denmark Details
GSK Investigational Site Copenhagen DK-2100 Denmark Details
GSK Investigational Site Herlev DK-2730 Denmark Details
GSK Investigational Site Odense 5000 Denmark Details
GSK Investigational Site Besançon Cedex 25030 France Details
GSK Investigational Site Lille 59000 France Details
GSK Investigational Site Montpellier Cedex 5 34298 France Details
GSK Investigational Site Nice 06189 France Details
GSK Investigational Site Saint Brieuc 22015 cedex France Details
GSK Investigational Site Saint-Herblain cedex 44805 France Details
GSK Investigational Site Heidelberg Baden-Wuerttemberg 69120 Germany Details
GSK Investigational Site Muenchen Bayern 81377 Germany Details
GSK Investigational Site Goettingen Niedersachsen 37075 Germany Details
GSK Investigational Site Hannover Niedersachsen 30177 Germany Details
GSK Investigational Site Duesseldorf Nordrhein-Westfalen 40217 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45122 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45136 Germany Details
GSK Investigational Site Dresden Sachsen 01307 Germany Details
GSK Investigational Site Kiel Schleswig-Holstein 24105 Germany Details
GSK Investigational Site Berlin 13353 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Szolnok 5004 Hungary Details
GSK Investigational Site Haifa 3109601 Israel Details
GSK Investigational Site Holon 58100 Israel Details
GSK Investigational Site Jerusalem 91031 Israel Details
GSK Investigational Site Jerusalem 91120 Israel Details
GSK Investigational Site Kfar-Saba 44281 Israel Details
GSK Investigational Site Rehovot 76100 Israel Details
GSK Investigational Site Tel Aviv 64239 Israel Details
GSK Investigational Site Tel Hashomer 52621 Israel Details
GSK Investigational Site Roma Lazio 00168 Italy Details
GSK Investigational Site Brescia Lombardia 25123 Italy Details
GSK Investigational Site Milano Lombardia 20141 Italy Details
GSK Investigational Site Catania Sicilia 95126 Italy Details
GSK Investigational Site MIlano 20133 Italy Details
GSK Investigational Site Bergen 5021 Norway Details
GSK Investigational Site Oslo 0379 Norway Details
GSK Investigational Site Bialystok 15-207 Poland Details
GSK Investigational Site Gdansk 80-219 Poland Details
GSK Investigational Site Lodz 94-029 Poland Details
GSK Investigational Site Poznan 60-569 Poland Details
GSK Investigational Site Oviedo Asturias 33011 Spain Details
GSK Investigational Site Barcelona 08907 Spain Details
GSK Investigational Site Barcelona 8035 Spain Details
GSK Investigational Site Madrid 28033 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Palma de Mallorca 07198 Spain Details
GSK Investigational Site Linköping SE-581 85 Sweden Details
GSK Investigational Site Lund SE-221 85 Sweden Details
GSK Investigational Site Stockholm SE-171 76 Sweden Details
GSK Investigational Site Nottingham Nottinghamshire NG5 1PB United Kingdom Details
GSK Investigational Site Yeovil Somerset BA21 4AT United Kingdom Details
GSK Investigational Site Birmingham West Midlands B18 7QH United Kingdom Details
GSK Investigational Site Bebington, Wirral CH63 4JY United Kingdom Details
GSK Investigational Site London NW1 2PG United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
GSK Investigational Site London SW36JJ United Kingdom Details
GSK Investigational Site Maidstone ME16 9QQ United Kingdom Details
GSK Investigational Site Rhyl LL18 5UJ United Kingdom Details
GSK Investigational Site Taunton TA1 5DA United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field